Related Experiment Video
Updated: Aug 9, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Pathophysiology of exacerbations of chronic obstructive pulmonary disease
Alberto Papi1, Fabrizio Luppi, Francesca Franco
1Department of Clinical and Experimental Medicine, Centre of Research on Asthma and COPD, University of Ferrara, Italy. fabbri.leonardo@unimo.it
Proceedings of the American Thoracic Society
|April 26, 2006
Summary
Chronic inflammation in COPD airways worsens during exacerbations, marked by increased immune cells and inflammatory mediators. This heightened inflammation drives the decline in lung function and overall health status.
Area of Science:
- Pulmonary Medicine
- Immunology
- Respiratory Health
Background:
- Stable chronic obstructive pulmonary disease (COPD) in smokers involves chronic airway inflammation.
- This inflammation is characterized by elevated macrophages and CD8 T lymphocytes in airway walls and neutrophils in the lumen.
Purpose of the Study:
- To detail the inflammatory changes during COPD exacerbations.
- To identify key mediators contributing to exacerbation-related lung function decline.
Main Methods:
- The study analyzes the cellular and molecular changes in the airways during COPD exacerbations.
- It focuses on the shifts in inflammatory patterns and mediator profiles.
Main Results:
- COPD exacerbations show altered inflammatory cell patterns, including increased eosinophils and/or neutrophils.
- Elevated levels of cytokines (e.g., TNF-α, RANTES), chemokines (e.g., CXCL8), chemokine receptors (e.g., CCR3), adhesion molecules (e.g., ICAM-1), and oxidative stress markers are observed.
Conclusions:
- Exacerbations represent a significant worsening of underlying chronic airway inflammation in COPD.
- This intensified inflammation is directly linked to the deterioration of lung function and clinical status.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...